Transmission Pathways of Foot-and-Mouth Disease Virus in the United Kingdom in 2007 by Cottam, Eleanor M. et al.
Transmission Pathways of Foot-and-Mouth Disease Virus
in the United Kingdom in 2007
Eleanor M. Cottam
1,2, Jemma Wadsworth
1, Andrew E. Shaw
1, Rebecca J. Rowlands
1, Lynnette Goatley
1,
Sushila Maan
1, Narender S. Maan
1, Peter P. C. Mertens
1, Katja Ebert
1, Yanmin Li
1, Eoin D. Ryan
1,
Nicholas Juleff
1, Nigel P. Ferris
1, John W. Wilesmith
3, Daniel T. Haydon
2, Donald P. King
1, David J.
Paton
1, Nick J. Knowles
1*
1Institute for Animal Health, Pirbright Laboratory, Pirbright, Woking, Surrey, United Kingdom, 2Division of Environmental and Evolutionary Biology, University of
Glasgow, Glasgow, United Kingdom, 3Animal Health and Welfare, Defra, London, United Kingdom
Abstract
Foot-and-mouth disease (FMD) virus causes an acute vesicular disease of domesticated and wild ruminants and pigs.
Identifying sources of FMD outbreaks is often confounded by incomplete epidemiological evidence and the numerous
routes by which virus can spread (movements of infected animals or their products, contaminated persons, objects, and
aerosols). Here, we show that the outbreaks of FMD in the United Kingdom in August 2007 were caused by a derivative of
FMDV O1 BFS 1860, a virus strain handled at two FMD laboratories located on a single site at Pirbright in Surrey. Genetic
analysis of complete viral genomes generated in real-time reveals a probable chain of transmission events, predicting
undisclosed infected premises, and connecting the second cluster of outbreaks in September to those in August. Complete
genome sequence analysis of FMD viruses conducted in real-time have identified the initial and intermediate sources of
these outbreaks and demonstrate the value of such techniques in providing information useful to contemporary disease
control programmes.
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Introduction
Foot-and-mouth disease (FMD) is an economically devastating
vesicular disease of domesticated and wild cloven-hoofed animals.
FMD is caused by a 30 nm un-enveloped virus belonging to the
genus Aphthovirus in the family Picornaviridae. Its genome consists of
a single strand of positive-sense RNA approximately 8.3 kb in
length [1] encoding a single polyprotein which is post-translation-
ally processed by virally-encoded proteinases [2]. FMD viruses
(FMDV) are divided into seven immunologically distinct serotypes
known as O, A, C, South African Territories (SAT) 1, SAT 2, SAT
3 and Asia 1. FMDV has a high mutation rate resulting in rapid
evolution and extensive variation between and within serotypes
[3].
The molecular epidemiology of FMDV has been extensively
studied [4,5]; and has allowed the tracing of outbreak origins on a
global scale [4]. Most of these studies have been conducted using
nucleotide sequences of one of the three major capsid-coding
genes (VP1) which represents less than 10% of the genome.
However, VP1 sequence data alone does not have the required
resolution for within-epidemic transmission tracing. In common
with some other RNA viruses, for example, human immunode-
ficiency virus (HIV) [6], hepatitis C virus (HCV) [7] and SARS
coronavirus [8], full genome sequence for FMDV has recently
been used for high-resolution molecular epidemiological studies
[9]. To date, fine scale tracing of pathogen transmission has
focussed on retrospective analysis; production of full-genome
sequences during the course of an outbreak (in real-time) may
assist in the interpretation of field epidemiology data and directly
influence measures to control the spread of the disease.
The UK 2007 FMD outbreaks have been characterised by the
emergence of two temporally and spatially distinct clusters. Eight
infected premises (IP1-8: designation of IP numbering is according
to The Department for Environment, Food and Rural Affairs
[Defra], UK) have been identified (Figure 1 and Table 1), two in
August and six in September. The first case (IP1b) was recognised
in beef cattle in a field off Westwood Lane, Normandy, Surrey,
UK. Samples collected on 3
rd August 2007 from animals
exhibiting suspect clinical signs were submitted to the World
Reference Laboratory for FMD located at the Institute for Animal
Health (IAH), Pirbright, Surrey. Within 24 hours, FMDV
sequence data obtained from the first IP (holding IP1b) revealed
a VP1 gene-identity of 99.84% to FMDV O1 British Field Sample
1860 (O1 BFS 1860); intratypic identities between type O VP1
sequences may be as low as 80% [4]. O1BFS 1860 is a widely used
reference and vaccine strain, originally derived from bovine
tongue epithelium received at the World Reference Laboratory for
FMD at Pirbright in 1967 from a farm near Wrexham, England.
The Pirbright site, comprising the laboratories of the IAH and
Merial Animal Health Limited (Merial), is situated 4.4 km from
PLoS Pathogens | www.plospathogens.org 1 April 2008 | Volume 4 | Issue 4 | e1000050the first IP. Both laboratories were working with the O1 BFS 1860
virus strain, making this site a likely source of the outbreak. Three
days after the case at IP1b, a second infected premises (IP2b) was
identified at Willey Green, approximately 1.5 Km from IP1b.
Cattle at a further holding (IP2c) near to and under the same
ownership as IP2b were found to be incubating disease at the time
of slaughter. Animals on both the affected farms were destroyed
and the premises were disinfected. Subsequent clinical and
serological surveillance within a 10 km control zone found no
evidence of further dissemination of FMD. However, on 12
th
September 2007, five weeks after the IP1 and IP2 cattle had been
culled, FMD was confirmed on the holding of a new IP (IP3b)
situated outside the 10 km control zone surrounding IP1 and IP2
(Figure 1). FMD outbreaks were subsequently reported on an
additional holding (IP3c) and five more premises (IP4, 5, 6, 7 and
8) all located close to IP3b and outside the original surveillance
area (Figure 1).
These outbreaks of FMDV in the UK during August and
September 2007 have caused severe disruption to the farming
sector and cost more than one hundred million pounds.
Investigating and determining the source of these outbreaks has
been imperative for their effective management and is vital for
future prevention. The aim of this study was to trace FMDV
movement from farm-to-farm by comparing complete genome
sequences acquired during the course of the epidemic. These
Author Summary
Foot-and-mouth disease (FMD) outbreaks in the United
Kingdom during August and September 2007 have caused
severe disruption to the farming sector and cost hundreds
of millions of pounds. Investigating and determining the
source of these outbreaks is imperative for their effective
management and future prevention. Foot-and-mouth
disease virus (FMDV) has a high mutation rate, resulting
in rapid evolution. We show how complete genome
sequences (acquired within 24–48 h of sample receipt) can
be used to track FMDV movement from farm to farm in
real time. This helped to determine the most likely source
of the outbreak, assisted ongoing epidemiological inves-
tigations as to whether these field cases were linked to
single or multiple releases from the source, and predicted
the existence of undetected intermediate infected
premises.
Figure 1. The geographical area affected by FMD outbreaks in 2007. The location of premises and holdings are shown (red circles, clinical
signs confirmed by laboratory analysis; yellow circles, FMDV detected using laboratory assays in the absence of clinical disease; and ﬂ, additional
holdings associated with FMD infected premises with no evidence of infection). The shaded areas denote the extent of the 5km protection zones and
10 km surveillance zones established (blue and green representing outbreaks in August and September respectively). The map also shows major
towns and motorways in the region and the location of the Pirbright site (star).
doi:10.1371/journal.ppat.1000050.g001
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the outbreak, assisted ongoing epidemiological investigations as to
whether these field cases were linked to single or multiple releases
from the source, and predicted the existence of undetected
intermediate infected premises that were subsequently identified.
Results/Discussion
The UK 2007 FMD outbreaks were characterised by the
emergence of two temporally and spatially distinct clusters. The
genetic relationships of FMDV present in eleven field samples
from the 2007 outbreak, three cell culture derived laboratory
viruses (see Table S1) used at the Pirbright site during July 2007
(designated IAH1, IAH2 and MAH) and a published sequence of
O1 BFS 1860 (AY593815) are illustrated in Figure 2A. Whereas
IAH1 and the virus from which the published sequence was
derived are believed to have been passaged no more than ten times
in cell cultures, the IAH2 and MAH viruses had been extensively
adapted to grow in a baby hamster kidney cell line (Table S1). In
natural hosts, FMDV attaches to integrin receptors on the cell
surface [10]. However, when grown in cell cultures, the virus may
adapt to attach to heparan sulphate (HS), through acquisition of
positively charged amino acid residues on the virus coat at
positions VP2
134 and/or VP3
56 [11,12]. An additional change
from a negatively charged amino acid residue at VP3
60 to a
neutral residue often occurs but may not be essential for HS
binding [11]. IAH1 and the previously sequenced isolate of O1
BFS 1860 have lysine at VP2
134, histidine at VP3
56 and aspartic
acid at VP3
60, none of the residues associated with HS binding,
whereas substitutions at VP3
56 (arginine) and VP3
60 (glycine) are
present in MAH and IAH2, consistent with their history of
extensive culture passage (Table 2). The presence of the HS
binding-associated substitution at residue VP3
60 (aspartic acid to
glycine) in all but one of the field viruses provides evidence that a
cell culture adapted virus is an ancestor of the outbreak. Since this
residue is not critical for HS binding it is less likely to undergo
reversion [11,12]. The wild type configurations at VP3
56 in all of
the outbreak viruses and at VP3
60 in the IP5 virus most likely
reflect reversions that have been selected upon replication within
the animal host. It is known that there is a strong selection pressure
for the reversion at VP3
56 when FMDV replicates in cattle [11].
The viruses from the outbreaks differ by at least five unique
synonymous substitutions from the laboratory viruses examined
(Table 2, Figure 2A). In terms of nucleotide substitutions, two very
Figure 2. Analysis of sequence data. A) Statistical parsimony analysis by TCS [19] of complete genome sequences of 14 FMDVs; connecting lines
represent a nucleotide substitution, thicker lines represent non-synonymous substitutions, with substitutions indicative of adaptation to cell culture
coloured green. Sequenced haplotypes (red circles), and putative ancestral virus haplotypes (white circles) are shown. AY593815 is a previously
published sequence [21] of FMDV O1 BFS 1860. The asterisk indicates the start of the tree in 2B). B) Lesion age derived infection profiles of holdings
overlaid with the outbreak virus geneology. The orange shading estimates the time when animals with lesions were present from the oldest lesion
age at post-mortem [22]. For IP2c, there were no clinical signs of disease. The light blue shading represents incubation periods for each holding,
estimated to begin no more than 14 days prior to appearance of lesions [23]. The dark blue shading is the infection date based on the most likely
incubation time for this strain of 2–5 days [24]. Each UK 2007 outbreak virus haplotype is plotted according to the time the sample was taken from
the affected animal (x axis). The dashed lines link the TCS tree together but do not denote any genetic change.
doi:10.1371/journal.ppat.1000050.g002
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the sequence of the virus from IP1b (6 and 7 substitutions,
respectively) compared with IAH1 (12 substitutions). Viruses IAH2
and MAH differ by only one non-synonymous change at amino
acid residue 2 of the Leader-b (Lb) polypeptide (a papain-like
cysteine proteinase) (Table 2). Since FMDV is known to exist as
variant populations of genetically related viruses [3], it is possible
that virus containing the MAH consensus sequence was present as
a minority component within the virus population of IAH2. It is
also possible that a reversion of the amino acid change at residue 2
of Lb could be selected when the virus goes back into the natural
host. Consequently, either of these viruses could be the source of
the 2007 outbreak.
Sequence analysis of virus from the first affected holding
identified in the second cluster of outbreaks (IP3b) demonstrated
that it had evolved from virus from the first cluster of outbreaks
(Figure 2A and B). The sequence data are not consistent with a
second escape of virus from the Pirbright site, as the virus from
IP3b shares five common nucleotide changes with IP1b and IP2c
and six in common with IP2b. A Bayesian majority rule consensus
tree, Figure S1, estimated in MrBayes [13] indicated that the
group linking the second cluster of outbreaks to the first is strongly
supported with a posterior probability greater than 0.999. An
alternative explanation that these outbreaks arose as a result of a
second release of virus that contained this combination of
mutations already is difficult to quantify precisely, however,
calculations using the highest estimate of population heterogeneity
(determined from in-vitro experiments; [14]) indicate that this
probability is still many magnitudes less likely than a single release
(data not shown).
During the second phase of the epidemic, analysis of the data
(within 24–48 hours: see Table 1) were rapidly reported to Defra
to inform field investigations. As an example, the virus from IP3b
was nine nucleotides different from the virus from IP1b (Table 2,
Figure 2A). This is a high number of changes for a single farm-to-
farm transmission (a retrospective study of virus genomes acquired
from sequentially infected farms during the UK 2001 outbreak in
Darlington, County Durham, found a mean of 4.5 (SD 2.1)
nucleotide changes [15]), and we predicted that there were likely
to be intermediate undetected infected premises between the first
outbreaks in August and IP3b. Subsequent field investigations
discovered IP4b and IP3c, which differed by one nucleotide from
each other. IP4b was three nucleotides closer to virus from the first
outbreaks, and IP3c also branched off the tree at this point.
However, there were still six nucleotide differences between
FMDV sourced from IP4b and FMDV sourced from the August
outbreaks. Serosurveillance of all sheep within 3 km of the
September outbreaks revealed another infected premises (IP5),
on which it was estimated that disease had been present for at least
two, and possibly up to five weeks. As Figure 2B shows, IP5 is a
likely link between the August and September outbreaks.
Epidemiological investigations suggest that animal movements
were not involved in the transmission of virus between premises,
but a variety of local spread mechanisms (such as movements of
contaminated persons, objects and aerosols) could account for the
transmission within each geographic and temporal cluster.
Although the epidemiological link between the August and
September clusters is not known, the genetic data provide strong
evidence to link FMDV transmission between these and the other
infected farms. The consensus sequences from individual farms
were found to differ by 1–5 nucleotide substitutions. It is probable
that the variation in number of changes observed (between
premises) have resulted from a number of factors including
variation in the degree of bottleneck on the transmitted virus
population by different transmission routes and number of virus
replication cycles that have occurred in the host post-transmission.
The genetic relationships between viruses from individual animals
shown in Figure 2A and B follows an identical topology to the
Bayesian majority rule consensus tree (Figure S1) and in-group
relationships are strongly supported by posterior probabilities on
genome groupings that were never less than 99%. Although a
more confident resolution of the IP-to-IP transmission pathways
might be achieved by characterising additional virus haplotypes
present on individual holdings, previous sequencing of virus
from different animals from the same farm conducted
following the UK 2001 outbreaks indicated very limited intra-
farm sequence variability [9]. Furthermore, the relationships
presented here reveal a transmission pathway between outbreaks
that is consistent with the estimates of when holdings became
infected and infectious (Figure 2B). The small number of
nucleotide substitutions observed between viruses from source
and recipient IP suggests that there has been direct transmission
without the involvement of other susceptible species, e.g. sheep or
deer.
Materials and Methods
Genome amplification and sequencing
Total RNA was extracted directly from a 10% epithelial
suspension using the RNeasy Mini Kit (Qiagen, Crawley, West
Sussex), or from blood or oesophageal/pharyngeal scrapings using
TRIzol (Invitrogen, Paisley, UK). Reverse transcription of the
RNA was performed using Superscript III reverse transcriptase
(Invitrogen) and an oligo-dT primer (see Table S2). Twenty four
PCR reactions per genome were performed with Platinum Taq
Hi-Fidelity (Invitrogen), using 23 primer sets tagged with forward
and reverse M13 universal primer sequences, and one primer set
with a oligo-dT reverse primer to obtain the very 39 end genomic
sequence (Table S2). The PCR products overlap such that each
nucleotide is covered by two products. The reactions were run on
a thermal cycling programme of 94uC for 2 min, followed by 40
cycles of 94uC for 30 s, 55uC for 30 s, 72uC for 1 min, with final
step at 72uC for 7 min. Sequencing reactions were performed
using the Beckman DTCS kit, with M13 universal forward and
reverse primers and specific forward and reverse primers for each
PCR product. This resulted in an average of 7.4 times coverage of
each base.
Sequence analysis
The raw data was assembled using the LasergeneH 7 Software
package (DNASTAR, Madison, WI) and all further sequence
manipulations were performed using BioEdit (version 7.0.1 [16])
and DNAsp (version 3.52 [17]). The data were analysed by
statistical parsimony methods [18] incorporated in the TCS
freeware [19]. A Bayesian majority rule consensus tree (based
on 10,000 trees sampled from 10 million generations)
was estimated in MrBayes [13] assuming a General Time
Reversible model of nucleotide substitution with invariant
sites (the model most strongly supported by more extensive
genome data from the UK 2001 outbreak, [15]. This analysis
was performed on consensus sequences as supported by
previous analysis of within individual viral diversity of
naturally infected animals based on results from cloning
the capsid genes (the most variable parts of the genome) that
show almost 50% of cloned sequences to be identical to the
consensus sequences and with an average pi (p) value of 7610
24
[20].
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Figure S1 A Bayesian majority rule consensus tree of all
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